Nabumetone
Product Images NDC 45865-111

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 45865-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nabumetone Tablets 750 mg (Pdp 111)

Nabumetone Tablets 750 mg generic for Relafen in a white and green label format. The label shows the product name, strength, and that it is an oval white film-coated tablet manufactured by ScieGen Pharm Inc. Instructions mention taking the tablet to prevent stomach upset. Lot and expiration date fields are visible along with peel area indicators for the label.*

FDA Label Image

Figure1 (Figure1)

A pharmacokinetic line graph depicting Nabumetone active metabolite (6MNA) plasma concentrations over 70 hours at steady state following once-daily dosing. It compares concentrations for 1000 mg and 2000 mg doses with shaded areas indicating ±2 standard deviations for each dose group, showing decline over time with labeled dose levels at around 44 hours.*

FDA Label Image

Structure1 (Structure1)

Chemical structure diagram of Nabumetone, showing its molecular formula C15H16O2 with a molecular weight of 228.3. The structure includes aromatic rings, a methoxy group, and a ketone functional group.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone. The diagram shows the molecular arrangement including a methoxy group (CH3O) and carboxylic acid group (COOH) attached to a naphthalene ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.